Correct Answer: A. 5 hydroxytryptamine
Serotonin is the common name for 5-hydroxytryptamine (5-HT), a monoamine neurotransmitter synthesized from the amino acid L-tryptophan. The biochemical pathway begins with tryptophan hydroxylase catalyzing hydroxylation of tryptophan to form 5-hydroxytryptophan (5-HTP), which is then decarboxylated by aromatic amino acid decarboxylase (AADC) to produce 5-HT. The nomenclature "5-hydroxy" refers to the hydroxyl group (-OH) attached at the 5-position of the indole ring of tryptophan, and "tryptamine" denotes the amine-containing derivative. This molecule is crucial in Indian clinical practice—deficiency is implicated in depression, anxiety, and sleep disorders commonly seen in outpatient psychiatry. The IUPAC name 5-hydroxytryptamine is the standard biochemical designation used in Harrison and KD Tripathi's pharmacology texts, making this the definitive answer for NEET PG examinations.
Why the other options are wrong
B. 5 hydroxytryptophan — This is wrong because 5-hydroxytryptophan (5-HTP) is an intermediate in serotonin synthesis, not serotonin itself. 5-HTP is the direct precursor formed after tryptophan hydroxylase acts on tryptophan; it still contains the carboxylic acid group and lacks the amine group. NBE exploits confusion between precursor and final product—students often conflate the synthesis pathway with the end molecule. C. 5 carboxy tryptophan — This is wrong because the 'carboxy' designation is misleading and non-standard. While tryptophan itself contains a carboxylic acid group (–COOH), the term '5-carboxytryptophan' does not correspond to any recognized neurotransmitter or metabolite. This is a distractor designed to confuse students who remember that tryptophan has a carboxyl group but fail to recognize that serotonin's defining feature is hydroxylation and decarboxylation, not carboxylation. D. 5 carboxy tryptamine — This is wrong because it combines two incorrect modifications: 'carboxy' (which serotonin does not retain) and 'tryptamine' (which is correct but paired with the wrong functional group). Serotonin is specifically a hydroxylated, decarboxylated derivative—it has lost the carboxylic acid group and gained a hydroxyl group. This option represents a common NBE trap pairing partially correct terminology with an incorrect chemical modification.
High-Yield Facts
- 5-hydroxytryptamine (5-HT) is synthesized from L-tryptophan via tryptophan hydroxylase and aromatic amino acid decarboxylase.
- Tryptophan hydroxylase requires tetrahydrofolate (BH₄) as a cofactor; deficiency impairs serotonin synthesis.
- 5-HTP is the immediate precursor to serotonin; it accumulates in carcinoid syndrome and is used therapeutically in some countries.
- Monoamine oxidase (MAO) degrades serotonin to 5-hydroxyindoleacetic acid (5-HIAA), measured in urine for carcinoid diagnosis.
- Serotonin dysfunction is implicated in depression, anxiety, OCD, and sleep disorders—core to Indian psychiatric practice and SSRI pharmacology.
Mnemonics
HT-PATH (Serotonin Synthesis) Hydroxylation (tryptophan → 5-HTP) → Then decarboxylation (5-HTP → 5-HT). Remember: Hydroxy comes first, Tryptamine is the final form. 5-HT = 5-Hydroxy-Tryptamine The '5' marks the position on the indole ring where the hydroxyl group attaches. 'Hydroxy' = –OH group. 'Tryptamine' = tryptophan minus the carboxyl group. Use this when you see '5-' in any option—it always refers to the indole ring position.
NBE Trap
NBE pairs 5-hydroxytryptophan (the precursor) with serotonin in the options to exploit students who confuse intermediates with end products in metabolic pathways. Students who memorize "tryptophan → 5-HTP → serotonin" may incorrectly select option B if they conflate the pathway with the molecule name.
Clinical Pearl
In Indian clinical practice, SSRIs (fluoxetine, sertraline, escitalopram) are first-line for depression and anxiety by blocking serotonin reuptake. Carcinoid syndrome—rare but important in Indian oncology—presents with diarrhea and flushing due to excess serotonin; urine 5-HIAA (serotonin's metabolite) is diagnostic. Understanding serotonin's biochemical identity is essential for interpreting both psychiatric medications and neuroendocrine tumor workup.
_Reference: KD Tripathi Pharmacology Ch. 5 (Neurotransmitters); Harrison Principles of Internal Medicine Ch. 397 (Serotonin Syndrome); Robbins Pathology Ch. 28 (Neuroendocrine tumors)_